AZGP1 anticorps (AA 61-210)

N° du produit ABIN7176718

Détail du produit anti-AZGP1 anticorps

Antigène: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Épitope: AA 61-210

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp AZGP1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Zinc-alpha-2-glycoprotein protein (61-210AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur AZGP1

Antigène: AZGP1 (alpha-2-Glycoprotein 1, Zinc-Binding (AZGP1))

Autre désignation: AZGP1 (AZGP1 Produits)

Synonymes: anticorps Zag, anticorps ZA2G, anticorps ZAG, anticorps ZA2GA, anticorps Zna2gp, anticorps alpha-2-glycoprotein 1, zinc, anticorps alpha-2-glycoprotein 1, zinc-binding, anticorps Azgp1, anticorps AZGP1

Sujet:

Background: Stimulates lipid degradation in adipocytes and causes the extensive fat losses associated with some advanced cancers. May bind polyunsaturated fatty acids.

Aliases: Alpha 2 glycoprotein 1 zinc antibody, Alpha 2 glycoprotein 1 zinc binding antibody, Alpha 2 glycoprotein zinc antibody, Azgp1 antibody, ZA2G antibody, ZA2G_HUMAN antibody, ZAG antibody, Zinc alpha 2 glycoprotein precursor antibody, Zinc-alpha-2-glycoprotein antibody, Zn alpha 2 glycoprotein antibody, Zn alpha 2 GP antibody, Zn alpha2 glycoprotein antibody, Zn-alpha-2-glycoprotein antibody, Zn-alpha-2-GP antibody, ZNGP1 antibody

UniProt: P25311

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process